Martingale Asset Management L P Has $3.17 Million Position in Phibro Animal Health Corporation (PAHC)

Martingale Asset Management L P increased its stake in shares of Phibro Animal Health Corporation (NASDAQ:PAHC) by 93.4% during the second quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The institutional investor owned 85,527 shares of the company’s stock after buying an additional 41,303 shares during the quarter. Martingale Asset Management L P owned about 0.22% of Phibro Animal Health Corporation worth $3,169,000 at the end of the most recent reporting period.

A number of other large investors also recently modified their holdings of PAHC. Bank of Montreal Can grew its position in Phibro Animal Health Corporation by 1,335.9% during the first quarter. Bank of Montreal Can now owns 44,886 shares of the company’s stock worth $1,261,000 after buying an additional 41,760 shares in the last quarter. Louisiana State Employees Retirement System boosted its holdings in shares of Phibro Animal Health Corporation by 1.4% in the 1st quarter. Louisiana State Employees Retirement System now owns 7,500 shares of the company’s stock valued at $211,000 after purchasing an additional 100 shares in the last quarter. Russell Investments Group Ltd. acquired a new stake in shares of Phibro Animal Health Corporation in the 1st quarter valued at $748,000. Wells Fargo & Company MN boosted its holdings in shares of Phibro Animal Health Corporation by 0.7% in the 1st quarter. Wells Fargo & Company MN now owns 125,941 shares of the company’s stock valued at $3,540,000 after purchasing an additional 932 shares in the last quarter. Finally, Great West Life Assurance Co. Can boosted its holdings in shares of Phibro Animal Health Corporation by 7.3% in the 1st quarter. Great West Life Assurance Co. Can now owns 26,554 shares of the company’s stock valued at $745,000 after purchasing an additional 1,802 shares in the last quarter. 48.35% of the stock is currently owned by institutional investors and hedge funds.

A number of equities research analysts have weighed in on PAHC shares. Credit Suisse Group downgraded Phibro Animal Health Corporation from an “outperform” rating to a “neutral” rating and raised their target price for the company from $29.00 to $36.00 in a report on Friday, June 2nd. BidaskClub downgraded Phibro Animal Health Corporation from a “strong-buy” rating to a “buy” rating in a report on Wednesday, June 14th. Piper Jaffray Companies set a $35.00 target price on Phibro Animal Health Corporation and gave the company a “buy” rating in a report on Friday, July 21st. Finally, Bank of America Corporation reaffirmed an “underperform” rating and issued a $33.00 target price on shares of Phibro Animal Health Corporation in a report on Wednesday, August 23rd. Two research analysts have rated the stock with a sell rating, one has given a hold rating and five have assigned a buy rating to the company. Phibro Animal Health Corporation currently has a consensus rating of “Hold” and a consensus price target of $34.00.

Shares of Phibro Animal Health Corporation (NASDAQ:PAHC) opened at 35.75 on Friday. The firm has a 50 day moving average price of $37.99 and a 200-day moving average price of $33.77. The firm has a market cap of $1.43 billion, a P/E ratio of 22.20 and a beta of 1.36. Phibro Animal Health Corporation has a one year low of $24.83 and a one year high of $40.25.

Phibro Animal Health Corporation (NASDAQ:PAHC) last released its quarterly earnings results on Wednesday, August 30th. The company reported $0.39 EPS for the quarter, beating analysts’ consensus estimates of $0.35 by $0.04. The firm had revenue of $194.84 million during the quarter, compared to analyst estimates of $192.47 million. Phibro Animal Health Corporation had a net margin of 8.45% and a return on equity of 47.88%. The business’s revenue for the quarter was up 3.0% on a year-over-year basis. During the same period in the previous year, the business earned $0.32 EPS. Analysts forecast that Phibro Animal Health Corporation will post $1.57 earnings per share for the current year.

The company also recently declared a quarterly dividend, which will be paid on Wednesday, September 27th. Stockholders of record on Wednesday, September 6th will be given a dividend of $0.10 per share. The ex-dividend date of this dividend is Friday, September 1st. This represents a $0.40 dividend on an annualized basis and a dividend yield of 1.12%. Phibro Animal Health Corporation’s dividend payout ratio (DPR) is currently 24.69%.

TRADEMARK VIOLATION WARNING: “Martingale Asset Management L P Has $3.17 Million Position in Phibro Animal Health Corporation (PAHC)” was first published by Transcript Daily and is the sole property of of Transcript Daily. If you are viewing this story on another website, it was illegally copied and reposted in violation of United States & international trademark & copyright legislation. The original version of this story can be accessed at https://transcriptdaily.com/2017/09/17/martingale-asset-management-l-p-has-3-17-million-position-in-phibro-animal-health-corporation-pahc.html.

In other news, CFO Richard G. Johnson sold 15,900 shares of the business’s stock in a transaction on Wednesday, September 13th. The shares were sold at an average price of $36.46, for a total transaction of $579,714.00. Following the completion of the transaction, the chief financial officer now directly owns 15,900 shares in the company, valued at approximately $579,714. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which can be accessed through the SEC website. Also, COO Larry Lee Miller sold 21,439 shares of the business’s stock in a transaction on Thursday, September 14th. The shares were sold at an average price of $36.43, for a total transaction of $781,022.77. Following the transaction, the chief operating officer now owns 15,891 shares of the company’s stock, valued at $578,909.13. The disclosure for this sale can be found here. Insiders have sold a total of 442,448 shares of company stock valued at $16,182,714 over the last 90 days. Company insiders own 48.09% of the company’s stock.

Phibro Animal Health Corporation Profile

Phibro Animal Health Corporation (Phibro) is a global diversified animal health and mineral nutrition company. The Company operates in three segments, which include Animal Health, Mineral Nutrition and Performance Products. The Company offers various products, which include Animal health products, such as antibacterials, anticoccidials, vaccines, nutritional specialty products and mineral nutrition products.

Institutional Ownership by Quarter for Phibro Animal Health Corporation (NASDAQ:PAHC)

Receive News & Ratings for Phibro Animal Health Corporation Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Phibro Animal Health Corporation and related companies with MarketBeat.com's FREE daily email newsletter.

Leave a Reply